Publication | Closed Access

Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy

CardiomyopathyHeart FailureCardiovascular DiseasePathologySerum Matrix MetalloproteinasesHypertrophic CardiomyopathyQuantitative BiomarkersAcute Myocardial InfarctionPublic HealthMedicineCardiologyEpidemiologyCardiac PathologyMyocardial Infarction